A Study Comparing a New Medication and Placebo to Treat Psoriasis

What we are studying

The purpose of this clinical research study is to determine the safety and effectiveness of an investigational study medication for the symptoms associated with plaque psoriasis.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed with plaque psoriasis
  • Cannot have received treatment with Enbrel

What is involved

  • Up to 5 years
  • Physical exam
  • Blood pressure
  • Electrical tracing of your heartbeat
  • Chest xray
  • Blood tests
  • Urine tests
  • Questionnaires
  • Treatment with an injectable medication

Compensation:

Up to $1,950, $50 per completed visit

Contact Information

Study Coordinator
Dermatology Clinical Studies
Email
dermadvertising@wakehealth.edu
Phone
336-716-3775

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.